Synthesis and characterization of the first cysteine-rich domain of novel protein kinase C
β Scribed by Yoshiaki Yanai; Kazuhiro Irie; Hajime Ohigashi; Paul A. Wender
- Publisher
- Elsevier Science
- Year
- 1997
- Tongue
- English
- Weight
- 318 KB
- Volume
- 7
- Category
- Article
- ISSN
- 0960-894X
No coin nor oath required. For personal study only.
β¦ Synopsis
The first cysteine-rich domains (CRD's) of mouse PKCq and PKC/~ (~I-CRDI and 6-CRD1) were prepared by automated solid phase peptide synthesis. In the presence of phosphatidylsenne, zinc-folded ~I-CRD 1 did not bind [-SH]phorlx)l 12,13-dibutyrate (PDBu) at all while the zinc-folded second CRD of mouse PKG1 (q-CRD2) bound PDBu strongly with a Kd of 0.91 nM. Moreover, 6-CRD1 showed very weak PDBu binding affinity (Kd = ca.500 nM) while the Kdof the second CRD of mouse PKC6 was reported to be 1.9 nM. These results suggest that the second CRD's of PKCrl and PKC6 play an important role in the PDBu binding.
π SIMILAR VOLUMES
The 116-mer peptlde contaaning the double cysteine-nch motifs of mouse protein kinase Cy (y-C 1A-C IB) has been synthesized using an Fmoc-solid phase strategy with a stepwise chain elongation. The peptide was purified only by reversed phase HPLC and gave satisfactory mass data (MALDI-TOF-MS and ESI-
## Abstract Human Dickkopfβ1 (huDKK1), an inhibitor of the canonical Wntβsignaling pathway that has been implicated in bone metabolism and other diseases, was expressed in engineered Chinese hamster ovary cells and purified. HuDKK1 is biologically active in a TCF/lefβluciferase reporter gene assay